Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer

SIMPLE SUMMARY: Circulating cell-free DNA (cfDNA) in patients with ampullary cancer was measured to clarify the correlation between cfDNA and clinicopathological factors and the impact of cfDNA on survival outcomes. The level of cfDNA was significantly higher in patients with lymph node involvement,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shyr, Bor-Uei, Shyr, Bor-Shiuan, Chen, Shih-Chin, Chang, Shih-Ching, Shyr, Yi-Ming, Wang, Shin-E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151754/
https://www.ncbi.nlm.nih.gov/pubmed/34065893
http://dx.doi.org/10.3390/cancers13102313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151754/
https://www.ncbi.nlm.nih.gov/pubmed/34065893
http://dx.doi.org/10.3390/cancers13102313

Ejemplares similares